Review of 20 years' clinical experience with retinoblastomas in Southern Taiwan

Chang Gung Medical Journal

Volumn 31, Issue 5, 2008, Pages 484-491

  Yang, I Hui ^a   Kuo, Hsi Kung ^a   Chen, Yung Jen ^a   Lee, Jong Jer ^a   Lin, Sue Ann ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Optic nerve invasion; Retinoblastoma; Survival analysis

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER INVASION; CLINICAL PRACTICE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EARLY DIAGNOSIS; ENUCLEATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HEMISPHERIC DOMINANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NERVE; PRESCHOOL CHILD; PROGNOSIS; RETINOBLASTOMA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TAIWAN; THERAPY DELAY;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TAIWAN;

EID: 54349088089     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004;24:828-48.
2. Balmer A, Zografos L, Munier F. Diagnosis and current management of retinoblastoma. Oncogene 2006;25:5341-9.
3. Abramson DH, Beaverson KL, Chang ST, Dunkel IJ, McCormick B. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol 2004;122:1316-23.
4. Shields JA, Shields CL, Sivalingam V. Decreasing frequency of enucleation in patients with retinoblastoma. Am J Ophthalmol 1989;108:185-8.
5. Shields CL, Santos MCM, Diniz W, Gunduz K, Mercado G, Cater JR, Shields JA. Thermotherapy for retinoblastoma. Arch Ophthalmol 1999;117:885-93.
6. Abramson DH, Schefler AC. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma. Technique and predictors of success. Ophthalmology 2004;111:984-91.
7. Shields CL, Shields JA, Kiratli H, De Potter PV. Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus 1995;32:317-22.
8. Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, Bunin GR, Meadows AT. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-7.
9. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1330-8.
10. Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, Toledano S, Markoe A, Murray TG. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol 2003;121:979-84.
11. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990;108:128-32.
12. The Committee for the National Registry of Retinoblastoma. Survival rate and risk factors for patients with retinoblastoma in Japan. Jpn J Ophthalmol 1992;36:121-31.
13. Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999;36:8-18.
14. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus 2000;37:134-41.
15. Kao LY, Su WW, Lin YW. Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000. Jpn J Ophthalmol 2002;46:577-80.
16. Messmer EP, Heinrich T, Höpping W, de Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 1991;98:136-41.
17. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology 1989;96:217-22.
18. Leal-Leal C, Flores-Rojo M, Medina-Sanson A, Cerecedo-Diaz F, Sanchez-Felix S, Gonzalez-Ramella O, Perez- Perez F, Gomez-Martinez R, Quero-Hernandez A, Altamirano-Alvarez E, Alejo-Gonzalez F, Figueroa-Carbajal J, Ellis-Irigoyan A, Tejocote-Romero I, Cervantes-Paz R, Pantoja-Guillen F, Vega-Vega L, Carrete-Ramirez F. A multicentre report from the Mexican retinoblastoma group. Br J Ophthalmol 2004;88:1074-7.
19. Goddard AG, Kingston JE, Hungerford JL. Delay in diagnosis of retinoblastoma: risk factors and treatment outcome. Br J Ophthalmol 1999;83:1320-3.
20. Erwenne CM, Franco EL. Age and lateness of referral as determinants of extraocular retinoblastoma. Ophthal Paediatr Genet 1989;10:179-84.
21. Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Carter J, Shields JA. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120:923-31.
22. Chantada GL, Dunkel IJ, de Dávila MTG, Abramson DH. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol 2004;88:1069-73.
23. Honavar SG, Singh AD. Management of advanced retinoblastoma. Ophthalmol Clin North Am 2005;18:65-73.
24. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64.